Press Releases - 2023-06-06

Date	Title	Company
06-Jun-2023	Nerve Repair and Regeneration Market Strong Growth at a CAGR of 6.5% and Revenue to Hit USD 12.3 billion by 2030	The Wire Times
06-Jun-2023	Multiple Myeloma Market 2023 Trends: Expected to Grow at a CAGR of 10.5% by 2031, Report	The Wire Times
06-Jun-2023	RWS Recognized for Exemplary ESG Performance and Best on Human Capital by EthiFinance	Businesswire
06-Jun-2023	UK Organisations Prioritise Actioning Threat intelligence but Lack Clear Path to Achieve it	Businesswire
06-Jun-2023	Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist	Businesswire
06-Jun-2023	ELRIG UK Announces Prof Janet Hemingway and Dr Dave Powell as Keynote Speakers at Drug Discovery 2023	ELRIG UK
06-Jun-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
06-Jun-2023	EVERSANA INTOUCH Wins Five Clio Awards	EVERSANA
06-Jun-2023	Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure	CSL Vifor
06-Jun-2023	Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for Acromegaly	Amolyt Pharma
06-Jun-2023	BIAL announces positive results from phase 3 study in early levodopa treated Parkinson’s disease patients without motor complications	BIAL
06-Jun-2023	Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care	AstraZeneca
06-Jun-2023	Anticounterfeiting in the spotlight as MM Packaging sponsors PHARMAP 2023 roundtable	MM Packaging
06-Jun-2023	KRW BioReg Solutions Ltd and Applied Biopharm Consulting Announce Strategic Partnership	KRW BioReg Solutions Ltd / Applied Biopharm Consulting
06-Jun-2023	VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics	VaxEquity
06-Jun-2023	BenevolentAI progresses BEN-34712 for the potential treatment of ALS into IND-enabling studies	BenevolentAI
06-Jun-2023	The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares	Moberg Pharma AB
06-Jun-2023	Transgene presents immunological data demonstrating that TG4001, a novel therapeutic cancer vaccine, can induce T-cell responses against HPV16 antigens in the ongoing Phase II trial at ASCO 2023	Transgene
06-Jun-2023	ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer	ImmunoGen Inc.
06-Jun-2023	Canton of Geneva supports Connect in Pharma 2023	Sciad Newswire